Quest Diagnostics Inc. (NYSE: DGX) last traded at $244.39, up 1.28% on the session. The quote above updates while this page is open; the figures below are drawn from Quest Diagnostics Inc.’s own filings and are restated only when a new one is published.
Quest Diagnostics Inc. trades on NYSE under the ticker DGX. Its market capitalisation is $26.97 billion.
Valuation measures for Quest Diagnostics Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $26.97B |
|---|---|
| P/E ratio | 25.94 |
| Price / sales | 2.33 |
| Price / book | 3.59 |
| Beta | -0.14 |
Trailing-twelve-month figures tagged in Quest Diagnostics Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $11.56B |
|---|---|
| Net income (TTM) | $1.06B |
| EPS (TTM) | $9.42 |
| Operating margin | 14.10% |
| Return on equity | 14.13% |
| Cash | $626.00M |
Range and volume for DGX over the past 52 weeks.
| 52-week high | $245.68 |
|---|---|
| 52-week low | $171.18 |
| Volume | 733.8K |
| Average volume | 935.3K |
| Previous close | $241.30 |
Dividend history for Quest Diagnostics Inc. over the trailing twelve months.
| Dividend yield | 1.36% |
|---|---|
| Dividend per share (TTM) | $3.32 |
| Payout ratio | 35.24% |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.